SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

MullenArmy members are actively debating the future of the MULN crypto token, with supporters framing it as a high-potential weekend runner primed for a V-shape reversal, while skeptics point to the project's history and recurring comparisons to previous stock market controversies. Community sentiment remains deeply polarized between those doubling down during dips and others warning of a pump-and-dump cycle.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following reports that the company is quietly building a stake in eBay for a potential takeover, fueling community debate about the viability of such a massive acquisition. While some investors see this as a bold move to leverage GameStop's cash reserves for a transformation into a retail giant, others are skeptical of the math and potential dilution, leading to intense speculation about short positions and the company's long-term strategy.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is seeing significant social media buzz and increased trading volume as the community rallies behind anticipated token burn mechanisms and potential legal developments. Investors are actively debating the token's long-term recovery prospects, with many holding positions in hopes of a major price resurgence.

Veil Cash is a privacy application leveraging zk-SNARKs on Base L2, enabling verified depositors to achieve privacy and anonymity within a pool of trusted users.  Veil Cash is a non-custodial privacy protocol on Base L2. Veil Cash's goal will be enabling verified users to achieve privacy and anonymity from trusted pools.  Veil is a set of smart contracts that will allow users that are deemed as verified users to deposit into the protocol. Users can later withdraw their deposits from another address without creating a link between these two addresses.   Verified users are those who meet certain criteria based on both on-chain and off-chain data.

Veil-project

The Veil project is gaining momentum as community members highlight its focus on privacy technology and its expansion within the Base ecosystem. Enthusiasts are actively discussing the token's potential for future growth, drawing comparisons to established privacy-focused assets.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include Core, Cognitive Adjacencies, and Network Software and Services. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

Arista Networks is currently a focal point for investors as the market monitors infrastructure-heavy beneficiaries of AI-driven capital expenditure, with ongoing community debate centering on whether recent price pullbacks represent a buying opportunity in a secular growth story or a reaction to broader macro volatility. Analysts remain largely constructive on the stock's long-term competitive positioning within the cloud and hyperscale networking sector, even as some participants express frustration over short-term price stagnation and volatility.

Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.

Oruka Therapeutics Inc.

Oruka Therapeutics is trending due to the release of positive interim Phase 2a trial results for its psoriasis drug, ORKA-001, which has sparked significant interest and analyst price target upgrades. While bulls are excited by the potential for annual dosing and best-in-class efficacy, some in the community remain skeptical, debating the long-term clinical risks associated with the drug's extended half-life and noting concerns over potential dilution from recent public offerings.

Roundhill ETF Trust - Roundhill Memory ETF

Investors are flocking to this ETF as a pure-play opportunity to capitalize on an industry-wide memory super-cycle, driven by the explosive demand for HBM and storage to support AI infrastructure. The community is highly bullish, viewing the sector as a critical bottleneck for AI growth and frequently discussing the potential for long-term supply constraints to keep margins elevated.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending as the community closely watches for upcoming phase 3 trial results, with active discussions focusing on the competitive landscape of IL-17 inhibitors and the potential for a favorable acquisition catalyst. Shareholders are debating the significance of recent insider equity activity and corporate filings while anticipating clarity on the 52-week clinical data as the primary driver for a significant revaluation of the stock.

WorldFinancial

WorldFinancial (WLFI) is trending amid intense community speculation regarding a proposed governance vote to implement a multi-year vesting schedule, a potential 4.5 billion token burn, and ongoing legal scrutiny involving major investors. While some holders anticipate that these supply-side adjustments and lockups will catalyze a significant price recovery, critics continue to label the project a scam, citing recent price declines and the controversial handling of investor liquidity.

Tidal Trust II - YieldMax Ultra Option Income Strategy ETF

YieldMax Ultra Option Income Strategy ETF

The YieldMax Ultra Option Income Strategy ETF (ULTY) is trending as investors react to a significant 1-for-10 reverse stock split and a strategic shift in the fund's portfolio holdings. Community discussions are heavily focused on navigating NAV erosion, debating the efficacy of the fund's new management strategy, and weighing the long-term sustainability of the fund's high-yield distribution model.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Humana (NYSE:HUM) Given New $214.00 Price Target at JPMorgan Chase & Co.

JPMorgan Chase & Co. upped their target price on Humana from $180.00 to $214.00 and gave the company a "neutral" rating in a research report on Friday...

Humana (NYSE:HUM) Stock Price Expected to Rise, Leerink Partners Analyst Says

Leerink Partners upped their price objective on shares of Humana from $185.00 to $255.00 and gave the company a "market perform" rating in a report on Thursday...

Jefferies Financial Group Issues Positive Forecast for Humana (NYSE:HUM) Stock Price

Jefferies Financial Group boosted their price objective on shares of Humana from $235.00 to $290.00 in a research note on Thursday...

Humana (NYSE:HUM) Price Target Raised to $195.00 at The Goldman Sachs Group

The Goldman Sachs Group lifted their price target on Humana from $158.00 to $195.00 and gave the company a "sell" rating in a report on Thursday...

Mizuho Forecasts Strong Price Appreciation for Humana (NYSE:HUM) Stock

Mizuho boosted their price target on shares of Humana from $258.00 to $290.00 in a research report on Thursday...

Humana (NYSE:HUM) Price Target Raised to $250.00

Evercore increased their target price on Humana from $195.00 to $250.00 in a research note on Thursday...

Humana (NYSE:HUM) Stock Price Expected to Rise, Cantor Fitzgerald Analyst Says

Cantor Fitzgerald upped their target price on Humana from $201.00 to $264.00 in a research note on Thursday...

Cigna Q1 Earnings Beat Estimates on Strong Evernorth Unit

CI beats Q1 EPS estimates as Evernorth revenues jump 9% despite rising pharmacy costs; 2026 EPS outlook lifted to at least $30.35.

Deutsche Bank Aktiengesellschaft Increases Humana (NYSE:HUM) Price Target to $235.00

Deutsche Bank Aktiengesellschaft increased their target price on shares of Humana from $180.00 to $235.00 and gave the stock a "hold" rating in a research note on Thursday...

Humana (NYSE:HUM) Price Target Raised to $270.00 at Truist Financial

Truist Financial boosted their price target on shares of Humana from $220.00 to $270.00 and gave the company a "hold" rating in a research report on Thursday...

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$6.42	--	--	N/A
Q1 '26	$10.20	$10.31	1.11%	BEAT
Q4 '25	-$4.00	-$3.96	1.05%	BEAT
Q3 '25	$2.93	$3.24	10.74%	BEAT
Q2 '25	$5.92	$6.27	5.95%	BEAT

HUM
Humana Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q1 '26

Historical Earnings

Latest HUM News

HUMHumana Inc